How much does Recordati Pharmaceuticals Limited make?

Recordati Pharmaceuticals Limited reported revenue of £12.7m and £199k profit in the year to 31 Dec 2025, according to its accounts filed at Companies House.

How many employees does Recordati Pharmaceuticals Limited have?

Recordati Pharmaceuticals Limited reported an average of 11 employees in the year to 31 Dec 2025.

Is Recordati Pharmaceuticals Limited profitable?

Yes — Recordati Pharmaceuticals Limited reported a profit of £199k in the year to 31 Dec 2025.

Company No. 05421174 · Incorporated 11 Apr 2005

Recordati Pharmaceuticals Limited

Registered name: RECORDATI PHARMACEUTICALS LIMITED

Part of Recordati Industria Chimica E Farmaceutica S.P.A. group

Recordati Pharmaceuticals Limited made £12.7m revenue and £199k profit in the year to 31 Dec 2025.

Recordati Pharmaceuticals Limited’s revenue grew 31% to £12.7m in the year to 31 Dec 2025, with £199k profit and 11 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Hemel Hempstead; we hold 4 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Hemel Hempstead, South East
Age: 21 yrs · since 2005
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2025

Key figures

Revenue

£12.7m

Growth ▲31.3%

Profit

£199k

Growth ▼66.6%

Profit margin

1.6%

Gross 29.4%

Employees

Change ▲83.3%

Profit / employee

£18.1k

Revenue/employee £1.2m

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2022	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£7.8m	£9.5m	£9.7m	£12.7m
Cost of sales	£4.7m	£6.8m	−£7m	−£9m
Gross profit	£3.1m	£2.7m	£2.7m	£3.7m
Operating profit	£1.1m	£935k	£286k	−£323k
Profit before tax	£1.2m	£1.3m	£807k	£133k
Profit after tax	£883k	£1m	£594k	£199k
Profit (best available)	£883k	£1m	£594k	£199k
Staff costs	£1m	£760k	—	—
Employees (average)	7	5	6	11
Ratios
Profit margin	11.3%	10.6%	6.1%	1.6%
Gross margin	39.5%	28%	27.5%	29.4%
Revenue per employee	£1.1m	£1.9m	£1.6m	£1.2m
Profit per employee	£126k	£201k	£99.1k	£18.1k
Growth (year on year)
Revenue growth	—	▲21%	▲2%	▲31.3%
Profit growth	—	▲13.8%	▼40.8%	▼66.6%
Headcount growth	—	▼28.6%	▲20%	▲83.3%
Balance sheet — indirect signals, not revenue
Cash at bank	£1.7m	£1.9m	—	—
Net assets	£11.6m	£12.6m	—	—
Fixed assets	£607	£0	—	—
Current assets	£16.1m	£15.3m	—	—
Debtors	£1.9m	£3.5m	—	—
Deferred income	£285k	£77.1k	—	—
Source	FullAccounts · bulk data Sep 2024	FullAccounts · bulk data Sep 2024	Accounts · bulk data May 2025	Accounts · bulk data Jul 2026

Derived from the latest filing

How the business works

Profit margin: 1.6%; Profit ÷ revenue.
Gross margin: 29.4%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £1.2m; Revenue ÷ average employees.
Profit per employee: £18.1k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now —
Cash at bank: —; Now —
Headcount: ▲83%; Now 11
Deferred income: —; Now —
Fixed assets: —; Now —

Corporate ownership

Group structure

Ownership chain

Recordati Industria Chimica E Farmaceutica S.P.A. (registered outside the UK register)ultimate parent75–100%
Recordati Pharmaceuticals Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from accounts for the year to 31 Dec 2025 (profit £199k), from the Companies House accounts bulk data published Jul 2026. Spotted an error? Request a correction.

Updated from Companies House on 12 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.